Comparative effectiveness of angiotensin receptor blockers vs. angiotensin-converting enzyme inhibitors on cardiovascular outcomes in patients initiating peritoneal dialysis

@article{Shen2016ComparativeEO,
  title={Comparative effectiveness of angiotensin receptor blockers vs. angiotensin-converting enzyme inhibitors on cardiovascular outcomes in patients initiating peritoneal dialysis},
  author={Jenny I Shen and Anjali Bhatt Saxena and Maria E. Montez-Rath and Lynn Leng and Tara I-Hsin Chang and Wolfgang C. Winkelmayer},
  journal={Journal of Nephrology},
  year={2016},
  volume={30},
  pages={281-288}
}
BackgroundThere is evidence that angiotensin-converting enzyme inhibitors (ACEI) and angiotensin-II receptor blockers (ARB) may reduce cardiovascular (CV) risk in patients undergoing peritoneal dialysis (PD), but no studies have compared the effectiveness between these drug classes. In this observational cohort study, we compared the association of ARB vs. ACEI use on CV outcomes in patients initiating PD.MethodsWe identified from the US Renal Data System all adult patients who initiated PD… CONTINUE READING